Amicus Therapeutics Inc (FOLD)
9.66
+0.16
(+1.68%)
USD |
NASDAQ |
Nov 22, 16:00
9.88
+0.22
(+2.28%)
After-Hours: 20:00
Amicus Therapeutics Revenue (TTM): 493.67M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 493.67M |
June 30, 2024 | 455.66M |
March 31, 2024 | 423.49M |
December 31, 2023 | 399.36M |
September 30, 2023 | 372.37M |
June 30, 2023 | 350.56M |
March 31, 2023 | 336.79M |
December 31, 2022 | 329.23M |
September 30, 2022 | 323.29M |
June 30, 2022 | 321.14M |
March 31, 2022 | 317.83M |
December 31, 2021 | 305.51M |
September 30, 2021 | 293.93M |
June 30, 2021 | 281.82M |
March 31, 2021 | 266.76M |
December 31, 2020 | 260.89M |
September 30, 2020 | 245.61M |
June 30, 2020 | 226.94M |
March 31, 2020 | 208.72M |
December 31, 2019 | 182.24M |
September 30, 2019 | 159.59M |
June 30, 2019 | 131.42M |
March 31, 2019 | 108.60M |
December 31, 2018 | 91.24M |
September 30, 2018 | 73.33M |
Date | Value |
---|---|
June 30, 2018 | 63.61M |
March 31, 2018 | 49.46M |
December 31, 2017 | 36.93M |
September 30, 2017 | 25.03M |
June 30, 2017 | 16.28M |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | 1.548M |
June 30, 2014 | 1.294M |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | 29.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
182.24M
Minimum
Dec 2019
493.67M
Maximum
Sep 2024
319.79M
Average
319.49M
Median
Revenue (TTM) Benchmarks
Tonix Pharmaceuticals Holding Corp | 11.29M |
Alnylam Pharmaceuticals Inc | 2.095B |
Insmed Inc | 342.96M |
Ionis Pharmaceuticals Inc | 803.07M |
Arbutus Biopharma Corp | 6.742M |